Any current/future new fundraising through debt or equity?

Meghmani Organics has done significant capex in FY21 and FY22, and currently does not foresee the need for significant capex in Agrochemical and Pigment divisions over the next 1-2 years. The focus will be on utilizing existing assets efficiently and reducing debt by repaying loans to bring down finance costs. No explicit mention of new fundraising through debt or equity was made in the call or transcript. The company aims to maintain relatively low-level debt. They plan to optimize operations first before considering new capex or associated fundraising. No announced or planned equity fundrais

Any current/future capex/capital investment/strategic investment?

Significant capex was done in FY21 and FY22; no major capex expected in Agrochemical and Pigment divisions for next 1-2 years. Focus will be on better utilization ("sweating") of existing new assets rather than new capex. Working on strategies to increase capacity by small de-bottlenecking to reduce manufacturing cost, especially in Pigments. Phase 2 capex for Titanium Dioxide (TiO2) plant is planned but currently exploring ways to increase existing plant capacity by 15-30% without major new capex. New subsidiary setup in Brazil is in final government approval stage, primarily for product regi

Future growth expectations in sales/revenue/volumes?

Agrochemical division volume growth was about 38% QoQ and over 50% YoY in the recent quarter, indicating strong momentum. New product introductions (e.g., Flubendiamide, Cyhalothrin, Beta Cyfluthrin, Spiromesifen) are expected to drive future growth. The Crop Protection division plans to run plants at 80-90% capacity utilization going forward. The multipurpose plant aims to expand product offerings significantly over the next 5-7 years, matching 25 years' output in a shorter time frame. Expansion targets are balanced between domestic (smaller volume demand) and export markets (about 80

Future growth expectations in earnings/operating earnings/profits/EPS?

Agrochemical division targets a sustainable 15% EBITDA margin in the near future, with volume growth around 38% this quarter and over 50% year-on-year. Introduction of multiple new, high-value products (Flubendiamide, Cyhalothrin, Beta Cyfluthrin, Spiromesifen, etc.) is expected to drive future revenue and margin growth. Crop protection segment capacity utilization currently at 84%, aimed at maintaining 80-90%, supporting volume expansion. Pigment segment aims to reach positive EBITDA, targeting around 10% margin; expects move to profitability in the next half. TiO2 plant to contribute from Q3

Meghmani Organics LtdQ2 FY25Fertilizers & Agrochemicals

Meghmani Organics Ltd Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹59.55P/E: 23.6Market Cap: ₹1.5K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

Agrochemical division volume growth was about 38% QoQ and over 50% YoY in the recent quarter, indicating strong momentum.
New product introductions (e.g., Flubendiamide, Cyhalothrin, Beta Cyfluthrin, Spiromesifen) are expected to drive future growth.
The Crop Protection division plans to run plants at 80-90% capacity utilization going forward.
The multipurpose plant aims to expand product offerings significantly over the next 5-7 years, matching 25 years' output in a shorter time frame.
Expansion targets are balanced between domestic (smaller volume demand) and export markets (about 80% revenue from exports) including U.S., Brazil, Latin America, and Africa.
Pigment segment capacity utilization stood at about 45%, with production up 24% YoY and revenue growing 23% YoY.
Overall, the company expects gradual improvement in pricing and demand, anticipating double-digit growth trajectory resumption.

Margin guidance

Category 3

Agrochemical division targets a sustainable 15% EBITDA margin in the near future, with volume growth around 38% this quarter and over 50% year-on-year.
Introduction of multiple new, high-value products (Flubendiamide, Cyhalothrin, Beta Cyfluthrin, Spiromesifen, etc.) is expected to drive future revenue and margin growth.
Crop protection segment capacity utilization currently at 84%, aimed at maintaining 80-90%, supporting volume expansion.
Pigment segment aims to reach positive EBITDA, targeting around 10% margin; expects move to profitability in the next half.
TiO2 plant to contribute from Q3 FY25 onwards, with price realization to improve following expected antidumping duties, aiding segment profitability.
Overall, improved price realization, better capacity utilization, and new product registrations are expected to boost operating earnings, profits, and EPS going forward.
Management expresses confidence in regaining double-digit growth trajectory backed by infrastructure and geographic reach.

See what Meghmani Organics Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Meghmani Organics has done significant capex in FY21 and FY22, and currently does not foresee the need for significant capex in Agrochemical and Pigment divisions over the next 1-2 years.
The focus will be on utilizing existing assets efficiently and reducing debt by repaying loans to bring down finance costs.
No explicit mention of new fundraising through debt or equity was made in the call or transcript.
The company aims to maintain relatively low-level debt.
They plan to optimize operations first before considering new capex or associated fundraising.
No announced or planned equity fundraising discussed in the transcript.

Order book

The transcript provided does not explicitly mention the current or expected order book or pending orders for Meghmani Organics Limited. However, some relevant insights include: - The company has introduced several new products in the last 2 years, including Flubendiamide, Cyhalothrin, Beta Cyfluthrin, Spiromesifen, Dinotefuran, and Ethiprole, indicating an active product pipeline. - Volume growth in the Crop Protection division was about 38% quarter-on-quarter and over 50% year-on-year, while Pigment volume grew more than 20%, reflecting strong demand. - The company is setting up a subsidiary in Brazil to hold product registrations independently, aiming to expand market reach and increase orders over the next 2-3 years. - Capacity utilization in Crop Protection is around 84%, planned to be maintained between 80-90%, supporting sustained order fulfillment. - No specific quantitative figures for order book or pending orders were disclosed in the transcript.

See what Meghmani Organics Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Significant capex was done in FY21 and FY22; no major capex expected in Agrochemical and Pigment divisions for next 1-2 years.
Focus will be on better utilization ("sweating") of existing new assets rather than new capex.
Working on strategies to increase capacity by small de-bottlenecking to reduce manufacturing cost, especially in Pigments.
Phase 2 capex for Titanium Dioxide (TiO2) plant is planned but currently exploring ways to increase existing plant capacity by 15-30% without major new capex.
New subsidiary setup in Brazil is in final government approval stage, primarily for product registrations, to capture Brazilian market.
Product registrations and new product launches continue to be a strategic focus, notably in Crop Protection division.
Debt reduction and cost of finance optimization expected as capex needs are low in near term.

Track Meghmani Organics Ltd — get its next earnings analysis in your feed

How does Meghmani Organics Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

ThisMeghmani Organics Ltd

Rev 2Mar 3

See where Meghmani Organics Ltd sits in Fertilizers & AgrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Meghmani Organics Ltd rank in Fertilizers & Agrochemicals?

Compare Meghmani Organics Ltd against every Fertilizers & Agrochemicals company (Q2 FY25) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

What Meghmani Organics Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Bhagiradha Chemicals & Industries Ltd (Q2 FY26)
140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran
Bhagiradha Chemicals & Industries Ltd (Q3 FY26)
114.0 crore, up 11% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q3 FY26 investor presentation — and how it ran
Advance Agrolife Ltd (Q3 FY26)
Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24). Key investor presentation takeaways
Dhansa Labs Ltd (Q4 FY26)
120-140 crores in additional annual revenue upon stabilization, with initial revenue of around Rs. Key concall takeaways from Dhansa Labs's Q4 FY26 earnings…

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs Sumitomo Chemical India Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →